×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TRAW – traws pharma, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TRAW
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/16
03:11 am
traw
Traws Pharma Inc (TRAW) Q4 2025 Earnings Call Highlights: A Turnaround Year with Significant ... [Yahoo! Finance]
Low
Report
Traws Pharma Inc (TRAW) Q4 2025 Earnings Call Highlights: A Turnaround Year with Significant ... [Yahoo! Finance]
4/16
12:43 am
traw
Traws Pharma, Inc. (TRAW) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Traws Pharma, Inc. (TRAW) Q4 2025 Earnings Call Transcript [Seeking Alpha]
4/15
08:12 pm
traw
Traws Pharma Announces Up to $60 Million Private Placement Financing [Yahoo! Finance]
Low
Report
Traws Pharma Announces Up to $60 Million Private Placement Financing [Yahoo! Finance]
4/15
04:01 pm
traw
Traws Pharma Reports Full Year 2025 Results and Provides Business Highlights
Medium
Report
Traws Pharma Reports Full Year 2025 Results and Provides Business Highlights
4/15
08:15 am
traw
Traws Pharma Announces Up to $60 Million Private Placement Financing
High
Report
Traws Pharma Announces Up to $60 Million Private Placement Financing
2/19
07:30 am
traw
Traws Pharma Completes Analysis of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients and Provides Updates for Additional Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza
High
Report
Traws Pharma Completes Analysis of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients and Provides Updates for Additional Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza
1/31
07:46 am
traw
Traws Pharma (NASDAQ:TRAW) was upgraded by analysts at LADENBURG THALM/SH SH to a "strong-buy" rating.
Medium
Report
Traws Pharma (NASDAQ:TRAW) was upgraded by analysts at LADENBURG THALM/SH SH to a "strong-buy" rating.
1/26
08:42 am
traw
Traws Pharma Completes Enrollment of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients; Announces Plans for Added Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza [Yahoo! Finance]
Medium
Report
Traws Pharma Completes Enrollment of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients; Announces Plans for Added Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/15
04:48 pm
traw
Form 10-K Traws Pharma, Inc. For: Dec 31
Medium
Report
Form 10-K Traws Pharma, Inc. For: Dec 31
4/15
04:02 pm
traw
Form 8-K Traws Pharma, Inc. For: Apr 15
Medium
Report
Form 8-K Traws Pharma, Inc. For: Apr 15
4/15
08:00 am
traw
Form 8-K Traws Pharma, Inc. For: Apr 15
High
Report
Form 8-K Traws Pharma, Inc. For: Apr 15
4/8
02:48 pm
traw
Form 4 Traws Pharma, Inc. For: Oct 12 Filed by: Parker Charles Nolan
Neutral
Report
Form 4 Traws Pharma, Inc. For: Oct 12 Filed by: Parker Charles Nolan
4/8
02:46 pm
traw
Form 3 Traws Pharma, Inc. For: Jul 03 Filed by: Parker Charles Nolan
Neutral
Report
Form 3 Traws Pharma, Inc. For: Jul 03 Filed by: Parker Charles Nolan
3/31
04:57 pm
traw
Form NT 10-K Traws Pharma, Inc. For: Dec 31
Medium
Report
Form NT 10-K Traws Pharma, Inc. For: Dec 31
3/10
07:23 pm
traw
Form 4 Traws Pharma, Inc. For: Mar 08 Filed by: Clarke Trafford
High
Report
Form 4 Traws Pharma, Inc. For: Mar 08 Filed by: Clarke Trafford
3/10
07:22 pm
traw
Form 4 Traws Pharma, Inc. For: Mar 08 Filed by: CAUTREELS WERNER
High
Report
Form 4 Traws Pharma, Inc. For: Mar 08 Filed by: CAUTREELS WERNER
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: